Quantifying cannabis use with the Timeline Followback approach: A psychometric evaluation

Drug and Alcohol Dependence

Volumn 121, Issue 3, 2012, Pages 247-252

  Norberg, Melissa M ^a   Mackenzie, Jennifer ^a   Copeland, Jan ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cannabis; Marijuana; Psychometric evaluation; Quantity of use; Timeline Followback

Indexed keywords

ADULT; ARTICLE; CANNABIS ADDICTION; CONCURRENT VALIDITY; CONTROLLED STUDY; DISCRIMINANT VALIDITY; DISEASE SEVERITY; FEMALE; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMETRY; QUANTITATIVE ANALYSIS; TEST RETEST RELIABILITY; TIMELINE FOLLOWBACK; WITHDRAWAL SYNDROME;

ADULT; AUSTRALIA; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SELF REPORT;

CANNABIS; CANNABIS SATIVA;

EID: 84857141292     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.09.007     Document Type: Article

References (29)

1. Australian Institute of Health and Welfare 2007 National Drug Strategy Household Survey: Detailed Findings. Cat. no. PHE 107 2008, Australian Institute of Health and Welfare, Canberra, ACT.
2. Akre C., Michaud P., Berchtold A., Suris J. Cannabis and tobacco use: where are the boundaries? A qualitative study on cannabis consumption modes among adolescents. Health Educ. Res. 2010, 25:74-82.
3. Amos A., Wiltshire S., Bostock Y., Haw S., McNeil A. You can't go without a fag ... you need it for your hash - a qualitative exploration of smoking, cannabis, and young people. Addiction 2004, 99:77-81.
4. Belendiuk K., Molina B.S.G., Donovan J.E. Concordance of adolescents reports of friend alcohol use, smoking, and deviant behavior as predicted by quality of relationship and demographic variables. J. Stud. Alcohol 2010, 71:253-257.
5. Copeland J., Gilmour S., Gates P., Swift W. The Cannabis Problems Questionnaire: factor structure, reliability, and validity. Drug Alcohol Depend. 2005, 80:313-319.
6. Copeland J., Swift W., Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. J. Subst. Abuse Treat. 2001, 20:45-52.
7. Donohue B., Azrin N.H., Stada M.J., Silver N.C., Teichner G., Murphy H. Psychometric evaluation of self- and collateral Timeline Follow-Back reports of drug and alcohol use in a sample of drug-abusing and conduct-disordered adolescents and their parents. Psychol. Addict. Behav. 2004, 18:184-189.
8. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The Timeline Followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psychol. 2000, 68:134-144.
9. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders 2002, Biometrics Research Department, New York.
10. Gossop M., Best D., Marsden J., Strang J. Test-retest reliability of the Seveirty of Dependence Scale. Addiction 1997, 92:353.
11. Hammersley R. A digest of memory phenomena for addiction research. Addiction 1994, 89:283-293.
12. Harrison L.D., Erickson P.G., Korf D.J., Brochu S., Benschop A. How much for a dime bag? An exploration of youth drug markets. Drug Alcohol Depend. 2007, 90S:S27-S39.
13. Heishman S.J., Evans R.J., Singleton E.G., Levin K.H., Copersino M.L., Gorelick D.A. Reliability and validity of a short form of the Marijuana Cravings Questionnaire. Drug Alcohol Depend. 2009, 102:35-40.
14. Highet G. The role of cannabis in supporting young people's cigarette smoking: a qualitative exploration. Health Educ. Res. 2004, 19:635-643.
15. Huang C., Liao H., Chang S. Social desirability and clinical self-report. J. Clin. Psychol. 1998, 54:517-528.
16. Knight G., Hansen S., Connor M., Poulsen H., McGovern C., Stacey J. The results of an experimental indoor hydroponic cannabis growing study, using the 'Screen of Green' (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis. Forensic Sci. Int. 2010, 202:36-44.
17. Lundahl L.H., Johanson C. Cue-induced craving for marijuana in cannabis-dependent adults. Exp. Clin. Psychopharmacol. 2011, 19:224-230.
18. Mariani J.J., Brooks D., Haney M., Levin F.R. Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend. 2011, 113:249-251.
19. McLaren J., Swift W., Dillon P., Allsop S. Cannabis potency and contamination. Addiction 2008, 103:1100-1109.
20. McRae-Clark A.L., Carter R.E., Price K.L., Baker N.L., Thomas S., Saladin M.E., Giaria K., Nicholas K., Brady K.T. Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals. Psychopharmacology (Berl) 2011, (epub. before print). 10.1007/s00213-011-2376-3.
21. Schwilke E.W., Gullberg R.G., Darwin W.D., Chiang C.N., Lud Cadet J., Gorelick D.A., Pope H.G., Huestis M.A. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction 2010, 106:499-506.
22. Sifaneck S.J., Ream G.L., Johnson B.D., Dunlap E. Retail marijuana purchases in designer and commercial markets in New York City: sales units, weights, and prices per gram. Drug Alcohol Depend. 2007, 90S:S40-S51.
23. Sobell L.C., Sobell M.C. Timeline Followback: A Calendar Method for Assessing Alcohol and Drug Use 1996, Addiction Research Foundation, Toronto.
24. Solowij N., Battisti R.A. The chronic effects of cannabis on memory in humans: a review. Curr. Drug Abuse Rev. 2008, 1:81-98.
25. Stasiewicz P.R., Vincent P.C., Bradizza C.M., Conners G.J., Maisto S.A., Mercer N.D. Factors affecting agreement between severely mentally ill alcohol abusers' and collaterals' reports of alcohol and other substance use. Psychol. Addict. Behav. 2008, 22:78-87.
26. Stephens R.S., Roffman R.A. Assessment of cannabis use disorders. Assessment of Addictive Behaviors 2005, The Guilford Press, New York. 2nd ed. D.M. Donovan, G.A. Marlatt (Eds.).
27. Strahan R., Gerbasi K.C. Short, homogeneous versions of the Marlow-Crowne Social Desirability Scale. J. Clin. Psychol. 1972, 28:191-193.
28. Walden N., Earleywine M. How high: quantity as a predictor of cannabis-related problems. Harm Reduct. J. 2008, 5:1-8.
29. XtremeHerbs.com.au. Marijuanilla 20g. Retrieved 24/August/2011, from http://www.xtremeherbs.com.au/herbs/marijuanilla-20g.html.